Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37
United States Fiscal year ends December CIK 0001821825 Results filed 30 Apr 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Lynette Holzbaur
6 May 2026
SVP and Corporate Controller
Buy
26,448
$13.35
$353.08K
Carrie Smith Cox
12 Nov 2025
Executive Chair
Buy indirect
65,400
$7.67
$501.76K
Carrie Smith Cox
14 May 2025
Director
Buy
12,469
$8.07
$100.59K
Aaron Falcione
7 May 2025
Chief Human Resources Officer
Buy
5,500
$8.77
$48.24K
Daniel Karp
6 May 2025
Executive VP, Corp. Dev.
Buy
3,500
$8.24
$28.83K
Kirke Weaver
6 May 2025
Gen. Counsel & Corp. Secy.
Buy
8,045
$9.21
$74.05K
Kevin Ali
5 May 2025
Chief Executive Officer
Buy
34,000
$8.81
$299.37K
Matthew M Walsh
5 May 2025
Chief Financial Officer
Buy
11,400
$8.82
$100.55K
Kirke Weaver
22 Feb 2024
Gen. Counsel & Corp. Secy.
Buy
2,720
$18.36
$49.94K
Ma. Fatima Francisco
19 Aug 2021
Director
Buy
3,000
$33.79
$101.37K

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 256,219,868
History held since 4 Jun 2021